Trulieve Cannabis Corp. (TRUL.CN) Deep Dive Video

Trulieve’s NYSE uplisting, Schedule III tax relief, and dominant medical cannabis footprint create a rare cash-generative cannabis platform with asymmetric upside—but IRS tax risk remains the key overhang.